ArticleFEMS microbiology letters2026
Decoupling ecological and pathogenic roles: Helicobacter pylori as a gastric hegemon maintaining order or amplifying dysbiotic chaos.
Article in FEMS microbiology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gastric dysbiosis refers to disease-associated alterations in microbial composition and between-individual variability. We postulate that Helicobacter pylori (H. pylori or Hp) exerts a context-dependent ecological effect across the Correa cascade-the histopathological progression from chronic gastritis through atrophic gastritis and intestinal metaplasia to gastric cancer-by constraining microbiome variation when acting alone but amplifying disease-associated divergence as pathology advances. We reanalyzed 756 gastric 16S rRNA gene profiles using Hill-number beta diversity and the Anna Karenina principle across three complementary schemes: (1) comparison of H. pylori infection status within each disease stage (Scheme-I); (2) disease progression in the Hp-negative cohorts, from healthy controls to successive disease stages (Scheme-II); and (3) disease progression in the Hp-positive, from healthy controls to successive disease stages (Scheme-III). We find: H. pylori alone consistently reduced microbiome divergence across disease stages, indicating a homogenizing effect rather than direct induction of dysbiosis. In contrast, progression to gastric cancer was the strongest driver of divergent dysbiosis, even in the absence of the bacterium. Most importantly, the presence of H. pylori caused dysbiotic divergence to emerge in multiple precancerous disease stages. These findings identify H. pylori as a context-dependent ecosystem modifier that maintains order in isolation but amplifies disease-associated dysbiosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.